The batch-to-batch assay performance ‘activity’ of antibody conjugated particles is often variable, leading to poor reproducibility between different production batches. DCS analysis provides a quantitative method to characterise particle oligomerisation, providing a rationale for variable assay performance of different conjugate batches.
No takes yet. Share an insight, caveat, or question.
Worsley et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: